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Severe combined immunodeficient (SCID)' mice have an autosomal recessive de-
fect that impairs the rearrangement of antigen receptor genes in lymphoid progen-
itors (1) . Consequently, functional lymphocytes do not develop and these animals
are severely lymphopenic (2, 3) . Recent resultshave demonstrated that human fetal
lymphoid tissue or peripheral blood lymphocytes from adults can survive in SLID
mice, and this has raised the possibility that this model system would be valuable
forthe study ofthe human immune response andlymphohernatopoietic abnormali-
ties (4, 5). A recent report suggests that acute infection of lymphoid cells in these
so called SLID-hu mice with human immunodeficiency virus is possible, but the
actual transfer of a lymphoid associated abnormalitywith human cells has not been
reported (6) .
To further study this model we injected PBL obtained from both normal volun-
teers and patients with primary biliary cirrhosis (PBC) into SCID mice. PBC is a
chronic autoimmune disease serologically characterized by the presence of autoan-
tibodies to the mitochondrialoxo-dehydrogenase enzymes and histologicallyby the
inflammation, specific obstruction, and eventual obliteration oftheintrahepatic bile
ducts (7-9) .
We report herein thetransfer of PBC-like characteristics to the immunodeficient
mice with PBLs from patients with PBC. Mitochondrial autoantibodies ofhuman
origin were presentin the serumofthe mice and biliary lesions that were apparently
due to human lymphoid cells that had infiltrated around the intrahepatic bile ducts
were present . A hepatic inflammatory reaction was also observed in mice that were
recipients ofPBLsfrom normal donors, suggesting thathumanlymphoid cells react
against murine tissues andcause a graft-vs.-host (GVH)-like disease in the animals .
Materials and Methods
Mice.
￿
HomozygousC.B-17 scid mice, designated SCID mice, were bred and maintained
in a barrier facility in the Division of Biomedical Sciences, University of California, River-
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side. Mice were housed in microisolator cages (Lab Products, Maywood, NJ) and kept in
a laminar flow portable clean room (AfroClean, Edgemont, PA). Animalswere not treated
with antibiotics and were healthy throughout the course of these experiments.
All manipulations were performed asceptically underalaminar flow hood including ob-
taining blood from the lateral tail vein 4 wk after PBL transfer. 8 wk after PBL transfer,
mice were exsanguinated and spleens and femurs were removed and placed in RPMI 1640
supplemented with 5% FCS. Single cell suspensions were prepared by teasingthetissue apart
with bent 18-gauge needles. After gentle aspiration with a pipette, cell suspensions were let
stand30 s to allowdebris to settle. Supernatants were then decanted. Bone marrow cellswere
treated in a similar manner after the marrow plug was flushed from the bones (10).
Preparation ofHumanPBL.
￿
Bloodsamplesfrom sixpatients with awell-established clinical
andlaboratory diagnosis of PBC andfrom five normal human volunteers were collected into
heparinized tubes. As shown in Table I, the histological stage of disease of the patients with
PBC varied. Two patients were stage II, three were stage III, and one was stage IV. PBMC
were isolated using Lymphoprep (Nycomed, Oslo, Norway). Plasma from the same patients
was frozen and subsequently used for serologic analysis. Based upon the cell dosage used
by others (5), between 10 and 42 x 106 PBLs in RPMI 1640 were injected intraperitoneally
into 5-8-wk-old male or female SCID mice. Up to three SLID mice were able to be recon-
stituted with the cells of any one patient.
Detection of Human Ig in SCID Sera.
￿
Human Ig were quantitated by a sandwich ELISA.
Polystyrene microtiter plates were coated with thecapture reagent, a 1:1,000 dilution ofgoat
anti-human Ig (IgG or IgM; Cappel Laboratories, Malvern, PA) in carbonate coating
buffer. After blocking, 10-fold dilutions of SCID sera in 1% BSA and standardized con-
trols were added to the wells. After incubation and washing, peroxidase-conjugated goat
anti-human polyvalent Ig (Tago Inc., Burlingame, CA) was used as the detection reagent.
Reactivity wasvisualized with 40.0 mM 2,2_azinobis 3-ethyl benthiazolenesulfonic acid (Sigma
TABLE I
Profile of SCID Mice Injected with Human PBL
" All mice were injected intraperitoneally.
t T cell subsets were also identified in reconstituted SCID spleens with CD3 positive cells: SCID recipients
that received PBLs from PBC donor 1, 66% CD4, 28% CD8; PBC donor 3, 2% CD4, I% CD8, PBC
donor 4, 0% CD4, 1 % CD8 PBC donor 6 0% CD4, 2% CD8. Normal donor 1 14% CD4, 56% CD8,
normal donor 2, 2% CD4, 16% CD8 and normal donor 3 3% CD4, 5% CD8.
No crossreactivity was noted between these monoclonal T cell markers and murine cells; thus 1 % was con-
sidered as real, i.e., positive, value.
Donor
Clinical
stage
Number of
PBL
transferred
SCID
recipients Outcome at 8 w
Percent splenic
CD3 cellst
x 106
PBC
1 II 10, 32 2 Human Ig'/AMA' 2/2, human T cells 1/2 63, 0
2 II 14 1 Human Ig'/AMA' 1/1, human T cells 0/1 0
3 III 14, 14, 45 3 Human Ig'/AMA' 3/3, human T cells 1/3 0, 0, 2
4 III 10 1 Human Ig'/AMA', 1/1 human T cells 1/1 1
5 III 21 1 Not analyzed serologically 0
6 IV 40, 40, 42 3 Human Ig'/AMA' 3/3, human T cells 1/3 0, 2, 0
Normals
1 N/A 11 1 Human Ig', AMA- , human T cells 1/1 56
2 N/A 36 1 Human Ig', AMA- , human T cells 1/1 16
3 N/A 28 1 Human Ig', AMA- , human T cells 1/1 5
4 N/A 27, 27 2 Human Ig', AMA- , human T cells 0/2 0, 0
5 N/A 28 1 Human Ig- , AMA- , human T cells 0/1 0KRAMS ET AL.
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Chemical Co., St. Louis, MO) in 0.05 M citric acid buffer, pH 4.2, containing 0.05 M H202.
The reaction was stopped after 5 min by the addition of 5% SDS.
In some experiments radial immunodiffusion plates to detect human IgG (Diffu-gen; Tago
Inc.) and low levelhuman IgM (AccraAssay, ICN ImmunoBiologicals, Lisle, IL) were used.
Sera from reconstituted and control SCID mice were incubated in parallel with standards
for 18 h to detect IgG and 44 h for IgM. Ig concentrations in SCID sera were determined
from a standard curve.
Identification of Human PBLs in SCID Mice by Immunojquorescence and Immunolabeling.
￿
Cells
that expressed various T cell surface antigens were identified by incubating 106 SCID spleen
cellsin 0.1 ml of4°C RPMI 1640 with mAbs to the following cell surface determinants: CD3
(Leu 4), CD4 (Leu 3a & 3b), and CD8 (Leu 2a) (Becton Dickinson & Co., Mountain View,
CA). After a 30-min incubation at 4°C, cells were washed in RPMI 1640 supplemented with
0.1% NaN3 and incubated an additional 30 min at 4°C with a fluorescein-conjugated
anti-mouse Ig (Tago Inc.). Cells were then washed twice in RPMI-NaN3, and fixed in 2%
paraformaldehyde. A FITC-labeled anti-human Ig antibody (Tago Inc.) was used to identify
human B cells by direct immunofluorescence. Cells were enumerated on a Leitz laborlux
microscopeequipped for epifluorescence. At least300 cells were counted per sample. In addi-
tion, the above protocol was performed on 106 cultured splenocytes from 6 PBC-reconstituted
and one normal reconstituted mouse in RPMI 1640 supplemented with 10% pooled human
AB serum and 100 U/ml human rIL-2 (Cetus Corp., Emeryville, CA). After 2 wk in culture
cells were removed, centrifuged onto microscope slides in a Cytospin 2 (Shandon Southern
Instruments Inc., Sewickley, PA), and acetone-fixed before indirect immunofluorescence.
Liver specimens were embedded in OCT compound (LabTek, Elkhart, IN), sectioned
at 6 um on a Tissue Tek cryostat (Miles Laboratories, Elkhart, IN) at -20'C, and placed
on gelatin-subbed slides. Immediately before use the tissue was fixed for 5 min at room tem-
perature in acetone and then washed in PBS, pH 7.4. Typing of T cell surface markers was
performed by indirect immunofluorescence. 100 pl of a 1 :200 dilution of anti-CD3, or one
drop ofanti-CD4 and anti-CD8 were added to individual tissue sections for 30 min at room
temperature. Antibody specificity was assessed by using a control serum on replicate sec-
tions. After two washes in PBS, goat F(ab')2 anti-mouse Ig-FITC was added for 30 min at
room temperature.
To detect Ig-bearing cells, liver specimens were embedded in paraffin, sectioned on a ro-
tary microscme, and mounted on gelatin-subbed slides. Slides were dried at 55°C for 2 h
before deparaffinization and rehydration. 20 Al of a 1 :100 dilution of polyvalent goat anti-
human FITC conjugate (Tago Inc.) was overlayed into slides placed in a room temperature
humidified incubator for 30 min. After washing in PBS, the sections were cover-slipped with
PBS-buffered glycerol. Sections were read on a Zeiss microscopeequipped for epifluorescence.
Auloantibodies to Mitochondria.
￿
The presence ofautoantibodies to the mitochondria) PDH-
E2 antigen in the sera of SCID mice was determined by ELISA and immunoblotting. For
the ELISA, pyruvate dehydrogenase (PDH; Sigma Chemical Co.) was used to coat polysty-
rene microtiter plates (Immulon, Dynatech Laboratories, Alexandria, VA) as previously de-
scribed (11-13). Plates were coated with 2 jig/ml of protein in carbonate coating buffer and
incubated at 4°C overnight after which time the plates were washed with 0.5% PBSTween
and blocked with 1% BSA-PBS. Twofold dilutions of serum from PBL reconstituted SCID
mice, plasma from the patients who donated cells, or normal control serum were dispensed
into individual wells in a volume of 0.1 ml in 1 % BSA-PBS for 1 h at room temperature.
After washing, the plates were incubated for 30 min with 100 J,1 of a goat anti-human peroxi-
dase conjugate diluted 1 :4000 (Tago Inc.).
An ELISA for quantitative determination ofantimitochondrial antibody (AMA) isotypes
recognizing PDH was similar to a previously described assay with the following modifica-
tions (11). After incubation with sera from reconstituted SCID mice and sera from PBC pa-
tients, plates were incubated with mAbs specific against human heavychain isotypes: SG-11
for IgG1, GOM-1 for IgG2, SJ-33 for IgG3, SK-44 for IgG4, and MB-11 for IgM (Miles
Scientific, Naperville, IL, and ICN, Lisle, IL). The binding of these mouse mAbs was de-
tected with peroxidase-conjugated goat anti-mouse IgG and IgM (Tago Inc.).
For the detection of AMAs by immunoblotting, samples were boiled for 3 min in SDS192 2
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sample buffer with 2-ME and the proteins were separated by 10% SDS-PAGE as previously
described (12). Each lane contained 30 Fig of protein in the case ofbeef heart mitochondria
(a gift from Dr. Brian Akrell, University of California, San Francisco, San Francisco, CA)
and 1 I~g of protein for PDH (a gift from Dr. Tom Roch, Kansas State University, Man-
hattan, KS). Separated proteins were then transferred to nitrocellulose paper (Schleicher &
Schuell, Inc., Keene, NH). 4-mm strips of the blotted nitrocellulose were cut, blocked with
"Blottd" (3% nonfat milk powder in PBS) for 30 min, and incubated for 1 h with 1 :100 dilu-
tion of sera from mice reconstituted with PBL from PBC patients. After three washes, the
strips were incubated with 0.3 ACi '151-labeled goat anti-human Ig for 1 h (Amersham Corp.,
Arlington Heights, IL). After three washes, the strips were dried and exposed to x-ray film
overnight. Plasma from the same patients with PBC and the same normal controls were used
as positive and negative controls.
Results
Human Ig are Present in PBL Reconstituted SCID Mice.
￿
Human Ig were detected
in the serum of 10 of 10 and 5 of 6 SCID recipients of PBLs from patients with
PBC or normal donors, respectively (Table I). The SCID recipient of PBLs from
PBC patient 5 was not analyzed serologically. IgG levels ranged from 0.1 to 3 .6 mg/ml
in SCID recipients of PBL from patients with PBC and from 0.0 to 6.3 mg/ml
in SCID mice that received PBLs from normal donors. In three PBL reconstituted
SCID mice, human IgM levels were higher than concentrations ofIgG. For example,
SCID mice that received PBL from PBC patient 6 have serum IgM levels of 3 .2
mg/ml and 2.5 mg/ml, while the IgG levels were only 2.4 mg/ml and 1.0 mg/ml,
respectively. In all of the SCID recipients of PBL from normal donors analyzed,
IgG levels were considerably higher than IgM (Table II).
TABLE 11
Levels of Human Ig in the Sera of SCID Sera
All sera were from animals 8 wk after being reconstituted.
' A, B, and C were used to designate different mice that received PBLs from
the same donor.
Sera Donor IgG IgM
mglml mglml
PBC-SCID IA` 0.6 0.2
iB 0.1 0.0
6A 2 .4 3.2
6B 1 .0 2.5
6C 0.2 0.0
3A 0.5 0.1
313 0.6 0.3
3C 0.1 0.0
2 0.1 0.1
4 3.6 4.8
5 ND ND
Nor-SCID 1 1 .0 0.1
2 6.3 0.9
3 1 .8 0.6
4 0.4 ND
5 0.6 ND
Unreconstituted SCID 0.0 0.0KRAMS ET AL .
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Presence ofHuman PBLs in SCID Mice.
￿
As shown in Table I, human lymphoid
cells were detected in the spleens of threeof six of theSCID recipients ofPBLs from
normal donors . Similar results were obtained with mice that received PBLs from
patients with PBC; CD3 + and CD8+ cells were detected in the spleens of 4 of 10
of these PBC-SCID mice, while CD4+ cells were present in the spleens of 2 of the
4CD3+ mice . Further evidence that humanT cells were present in the spleen was
obtained by indirect immunofluorescence on cytospin preparation prepared from
cultured splenocytes (data not shown) . Thus, the extent of reconstitution was vari-
able in these SCID mice even when healthy animals ofthe same litter andthe number
of cells from the same donorwere used . None of the cells in the spleen suspensions
stained with anti-human Ig, although Ig' cells were present in the liver (Fig . 1) .
AMAs ofHuman Origin are Present in PBCReconstitutedMice.
￿
10 of 10 reconstituted
mice that were serologically analyzed and received an injection of cells from the
patients with PBC had serum antibodies that reacted with thePDH complex (Fig.
2) . Furthermore, immunoblots with beefheart mitochondria and purified pyruvate
dehydrogenase confirmed specific reactivity to the mitochondrial antigens (Fig. 3) .
The isotype distribution ofAMAs in thePBC reconstituted animals was further
analyzed by ELISA. As shown in Fig . 4, AMAs ofIgM and all the IgG subclasses
were detected . Patients with PBC typically have AMAs that are predominantly of
the IgG3 andIgM isotypes (11) . In three offour cases, PBC-reconstituted mice with
AMAs that were predominantly IgM also had high levels of total human IgM im-
munoglobulin .
Histological Appearance of Tissue.
￿
In8 of 11 SCID recipients ofPBLs from patients
FIGURE 1 .
￿
Immunolluorescence analysis of human Ig in liver obtained from a SCID mouse
reconstituted with PBLs from PBC patient 4from Table 1 . Ig' cells are seen in the mononuclear
lymphoid infiltrate.1924
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FIGURE 2 .
￿
Detection ofAMAs
in reconstituted SCID sera by
ELISA. Themean optical den-
sity t SD values are for tripli-
cate wells at a 1 :100 dilution of
SCID sera. Sera from mice re-
constituted withPBLfrom nor-
mal healthy donorsand unrecon-
stituted SCID sera did not give
optical density values above
those of background controls .
(A, B, and C) Different mice
that received PBL from the
same donor.
FtGuRE 3.
￿
Reactivity ofSCID sera against
(1) Purified pyruvatedehydrogenase com-
plex, and (2)beefheart mitochondria. The
proteins were separated by SDS-PAGE,
blotted onto nitrocellulose paper, and
probed with 1:100 dilution ofPBC plasma
(lane A), 1:100 dilution of reconstituted
SCID sera from thesame patient (lane B),
1 :100 dilution of normal reconstituted
SCID sera (lane C), 1:100 dilution ofPBC-
reconstitutedSCID sera from a different
patient withPBC (lane D), or a 1:100 di-
lution of plasma from a normal donor.
Notethat the serum from the reconstituted
SCID mouse reactswith the same proteins
as does the plasma from the patient with
PBC; the 74-kD dihydrolipoamide acetyl-
transferase, the56-kD antigen is the pro-
teinXofthePDC thatpossessescrossreac-
tiveAMA epitope(s) withthe 74-kD antigen
(9). The 48-kD antigen may be the Ela
ofthePDC . Theremaining bands are pre-
sumed to be degradation products as pre-
viously reported (11, 12) .KRAMS ET AL .
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FIGURE 4 .
￿
Detection ofAMA isotypes by ELISA. Mean optical density t SD values of the
sera from SCID mice injected with PBL from patients with PBC. Mean optical density t SD
values of the plasma from these six patients withPBC were: IgM, 0.760 t 0.167 ; IgG3, 0.336
t 0.114; IgGl, 0.046 t 0.002 ; IgG2, 0.196 t 0.065; and IgG4, 0.076 t 0.010 . The isotype
distribution of PBC-reconstituted SCID mice 113, 3B, and 3C could not be determined due to
the low titers ofAMA in theserum . A, B, and Cwere used to indicate different mice that received
PBLs from the same PBC donor.
with PBC, an infiltration of inflammatory cells consisting primarily oflymphocytes
includingplasma cells was observed around the portal areas ofthe liver. The mono-
nuclear infiltrate was consistently localized around the bile duct and ranged from
mild to severe (Fig . 5, A, B) . Degenerative changes or destruction ofthe bile ducts
were observed in 7 of 11 PBC-reconstituted mice with cellular infiltrates . Fibrosis
and necrosis were also noted in these sections (Table III).
Theliver sections from SCID mice reconstituted with normal PBLs also exhibited
mild to moderately severe mononuclear cell infiltrates (Fig . 5 C),but bile ductdamage
and hepatocyte necrosis were only seen in one of six mice with the most intense
infiltration. No evidence of inflammation or a mononuclear infiltrate was present
in the liver of unreconstituted SCID mice (Fig . 5 D) . In addition, tissue sections
of skin, lung, and gut from five PBC-reconstituted mice and five normal reconstituted
mice revealed no abnormalities.
ImmunohistochemicalEvaluation ofLiverSections.
￿
The lymphoid infiltrate surrounding
the bile ducts in the liver of normal andPBC reconstituted SCID mice was exam-
ined using specific mAbs. Liversections from three ofthree PBC-reconstituted SCID
mice and three ofthree normal reconstituted SCID mice contained CD3+ , CD4',1926
Inflammation
Bile duct atypia
Necrosis
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Percentage of PBC-
reconstituted SCID
mice displaying
liver pathology`
72.7 (8/11)
63.6 (7/11)
54.5 (6/11)
TABLE III
Summary of Liver Histology
Percentage of normal
donor reconstituted
SCID mice displaying
liver pathology
66.6(4/6)
16.6 (1/6)
16.6(1/6)
" Pathology was assessed in mice 8 wk after injection of human PBLs.
Percentage of
unreconstituted
SCID mice displaying
liver pathology
0 (0/2)
0 (0/2)
0(0/2)
and CD8' T cells (data not shown). Ig' cells were seen in four of four PBC-
reconstituted SCIDmice andthreeoffournormal-reconstituted SCIDmice analyzed.
Discussion
Thedata herein confirm a previous report that human peripheralbloodlympho-
cytes can reconstitute T and B cells and serum Ig of human origin in mice with
severe combined immunodeficiency disease. The purpose ofthe present study was
toextend these observations and investigate whether immune system abnormalities
could be duplicated in SCID mice by transfer of PBL. The data indicate that PBL
from patientswith the autoimmune condition PBC transferred many ofthecharac-
teristics of the disease to the immunodeficient mice. A second important finding
from these studies wasthat thetransferof PBL, evenfrom normal donors, produced
a GVH-like condition in the liver of the animals.
Attempts to develop an animal model of PBC have been made, but these have
duplicated only selected aspects ofthe disease (14-16). For example, we have previ-
ously demonstrated that immunization ofvarious species of animals with recom-
binant dihydrolipoamide acetyltransferase resulted in the generation ofAMAs, but
hepatic pathology was not exhibited (12). The PBC-SCID mice described herein
contained the characteristic AMAs reactive with the major mitochondrial autoan-
tigen, dihydrolipoamide acetyltransferase (E2, EC 2.3.1.12) of the PDH complex.
In addition, the animals presented with marked hepatic infiltrates of human
mononuclearcells thatwere localized around the intrahepatic bile ducts ofthePBC
reconstituted mice. The lesions associated with these infiltrates consisted of lym-
phoid cell invasion ofthe bile duct epithelium accompanied by subsequent cellular
destruction. These infiltrating lymphocytes consisted of CD3', CD4', and CD8'
cells, aswellasplasma cells. Thisis consistent withthe fact thatmononuclearinfiltrates
in the early stages of PBC contain T lymphocytes, most of which are CD4' with
a smaller number of CD8+ cells immediately surrounding the bile duct (7). A re-
cent report demonstrates that CD8' cells are the predominant T cell subset that
migrates out ofstage 11 or III liver in culture (17). Thus, the above findings are the
first to report an animal model in which both the cellular and humoral aspects of
the disease are present.
SCID mice that received a graft of PBL from normal donors also developed a
hepatic inflammatory reaction. The strongest reaction occurred in a SCID mouse
that received cells from a healthy female who has routinely handled mice for theKRAMS ET AL . 1927
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past 10 yr, and GVH response mediated by sensitized T cells must be considered
in this case. The lesions resembled those in patients with GVH disease during he-
patic allograft rejection (18). It has been hypothesized that the bile duct lesions that
characterize the GVH reaction seen in patients after liver transplantation are due
to sensitized graft T lymphocytes selectively attacking MHC class II bearing bile
duct epithelial cells (19, 20). Aberrant expression ofMHC class II antigens on bile
duct epithelium hasbeen observedin patientswith GVHdisease afterbone marrow
transplantation aswell (20-22). Minorhistocompatibility antigens expressedin host
biliary epithelial cells are thought to account for the preferential horning ofmono-
nuclear cells to the hepatic portal spaces and the resulting GVH in a recently de-
scribed murine chronicGVH disease (23). These datathus indicate that reconstitu-
tion ofSCID mice with human cells may prove to be an important model ofvalue
in GVH studies.
Bile duct lesions resemblingchronic nonsuppurative destructive cholangitis seen
in PBC was recently reported in a murine model in which B6 splenocytes were in-
jected into B6 x bm12 F1 recipients (24). These mice developed an inflammatory
infiltrate, consistingoflymphocytes, plasma cells, and eosinophils, around the small
bile ducts and were hypothesized to serve as a model ofPBC eventhough no AMAs
were observed. It is possible that the bile duct lesions in the PBC SCID mice are
due to a similar GVH-like reaction. This could, in fact, prove to be an important
event in the development of AMAs in the mice. Upon destruction of the bile duct
cells, mitochondrialantigens couldbecome accessible to the autoreactive B cellspresent
in the patient's PBLs that were transferred into the mice. Since the mitochondrial
antigens towhich the AMAs react are highly conserved, the presence ofmouse an-
tigenwouldbe expected tostimulatethe humanB cells. In this case, then, theGVH-
like liverdamage and the development ofAMAswould belinked and the mice actu-
ally develop a PBC-like condition.
Ifthe above events actually do occur, then the transfer ofPBLs result in the devel-
opment ofdisease. This remains highly speculative, however. It remains to be for-
mally proven whether actual disease is duplicated in the mice or they simply serve
as an in vivo reservoir in which abnormal lymphoid populations are maintained.
In the latter case the presence of AMAs would not be due to reactivity against a
conserved murine antigen but rather to spontaneous secretion ofautoantibodies by
thehumancells. This and other important issues, such as the variabilityofreconsti-
tution even when animals of the same litter are used as recipients of comparable
numbers of cells from the same donor, remain to be resolved in the use of these
mice for the study of human lymphoid abnormalities.
Summary
Human PBL have been reported to reconstitute B and T cells as well as human
serum Iginmice withsevere combined immunodeficiency disease(SCID). Toconfirm
these observations and attempt the transfer of an autoimmune disease to the im-
munodeficient animals, groups of SCID mice received an injection of PBL from
patients with primary biliary cirrhosis (PBC) or from normal volunteers. By 8 wk
after the injection of 10-42 x 106 PBL into the mice, human lymphoid cells were
detected in the spleen ofapproximately halfof the animals and all had detectable
serum levels of human IgG. Moreover, the sera of SCID mice that received cellsfrom patients with PBC contained human antimitochondrial antibodies (AMA) to
dihydrolipoamide acetyltransferase, the major mitochondrial autoantigen of PBC .
Histologically, a human mononuclear cell infiltrate was present around the portal
areas of the liver and inflammation, bile duct atypica, and necrosis ofbile duct cells
were observed. While the biliary lesions in the SLID recipients of PBC cells were
more severe, a mononuclear infiltrate was clearly evident in mice that received cells
from normal donors, suggesting the presence of a graft-vs.-host-like disease. While
these data are the first to describe an animal model with both the humoral and cel-
lular characteristics of PBC, they also raise an interesting question regarding the
preferential localization of lymphoid cells to the biliary system.
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